当前位置:首页 - 行情中心 - 诚意药业(603811) - 财务分析 - 利润表

诚意药业

(603811)

  

流通市值:32.83亿  总市值:32.83亿
流通股本:3.27亿   总股本:3.27亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入185,591,983.95714,369,070.89520,542,330.59355,789,053.38
营业收入185,591,983.95714,369,070.89520,542,330.59355,789,053.38
二、营业总成本140,420,568.18597,581,244.1437,021,620.72291,534,398.15
营业成本57,588,093.59217,642,521.57161,290,949.46107,760,670.41
税金及附加3,702,201.4814,329,993.1910,863,071.946,774,261.69
销售费用43,626,154.81182,568,105.39132,692,285.9794,108,676.09
管理费用26,418,166.68127,852,670.7888,823,175.3155,927,218.49
研发费用7,660,759.1247,084,603.4337,135,931.4222,986,655.44
财务费用1,425,192.58,103,349.746,216,206.623,976,916.03
其中:利息费用1,317,196.4211,091,000.938,799,172.076,659,716.87
其中:利息收入51,924.63,043,495.332,960,701.092,775,272.91
加:投资收益9,494,809.9443,238,688.3630,981,776.8819,862,597.26
资产处置收益44,706.169,168,227.388,359,205.6-
资产减值损失(新)-2,218,785.13-26,596,192.71-2,496,163.19-3,638,319.65
信用减值损失(新)-282,021.252,313,007.941,527,916.8461,813.87
其他收益1,528,687.816,294,325.018,310,319.956,147,826.87
营业利润平衡项目0000
四、营业利润53,738,813.23221,205,882.77130,203,765.9187,088,573.58
加:营业外收入116,178.33807,385.52770,885.81756,955.96
减:营业外支出520,766.233,879,301.72684,770.3496,459.25
利润总额平衡项目0000
五、利润总额53,334,225.33218,133,966.57130,289,881.4287,349,070.29
减:所得税费用6,465,512.3717,347,706.3913,280,729.610,833,220.78
六、净利润46,868,712.96200,786,260.18117,009,151.8276,515,849.51
持续经营净利润46,868,712.96200,786,260.18117,009,151.8276,515,849.51
归属于母公司股东的净利润45,793,170.61200,700,773.72117,073,573.8776,465,500.27
少数股东损益1,075,542.3585,486.46-64,422.0550,349.24
(一)基本每股收益0.140.610.360.23
(二)稀释每股收益0.140.610.360.23
八、其他综合收益--229,502.1629,129.1721,298.43
归属于母公司股东的其他综合收益--206,551.9426,216.2519,168.59
九、综合收益总额46,868,712.96200,556,758.02117,038,280.9976,537,147.94
归属于母公司股东的综合收益总额45,793,170.61200,494,221.78117,099,790.1276,484,668.86
归属于少数股东的综合收益总额1,075,542.3562,536.24-61,509.1352,479.08
公告日期2025-04-302025-04-302024-10-292024-08-21
审计意见(境内)标准无保留意见
TOP↑